ArticleJornal brasileiro de nefrologia
Renal osteodystrophy in a sample of patients on dialysis in Northeastern Brazil: a cross-sectional analysis.
Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Renal osteodystrophy in Brazil: the skeleton calls for greater attention!Jornal brasileiro de nefrologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMineral and bone meta-bolism disorders in chronic kidney disease (CKD-MBD) are one of the most significant complications of CKD. The objective of this study was to describe the types of renal osteodystrophy (ROD) and the clinical and osteometabolic profiles of dialysis patients undergoing bone biopsy in Pernambuco.
methodsA cross-sectional, retrospective study that assessed patients biopsied between January 2004 and September 2021 was conducted. Patients receiving conservative treatment for CKD, kidney transplant recipients, and those with inadequate biopsies were excluded. All clinical and laboratory parameters were from the time of biopsy.
resultsWe assessed 250 patients with median age of 48 years (57.6% women) and on dialysis for a median time of 108 months. Regarding the diagnosis of ROD, the prevalence was: osteitis fibrosa (54.5%), mixed disease (30.4%), adynamic bone disease (12.4%), and osteomalacia (3.2%). The prevalences of osteoporosis, aluminum toxicity, and iron toxicity were 43.6%, 46.8% and 27.5%, respectively.
conclusionsWe demonstrated a high prevalence of diseases related to high bone turnover and aluminum toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.